Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Current preclinical models to investigate human HR + breast cancer progression and response to immunotherapy in vivo are limited. Here, the authors demonstrate that mammary tumours driven by a synthetic progestin combined with an oral carcinogen recapitulate several immunobiological features of huma...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Aitziber Buqué, Norma Bloy, Maria Perez-Lanzón, Kristina Iribarren, Juliette Humeau, Jonathan G. Pol, Sarah Levesque, Laura Mondragon, Takahiro Yamazaki, Ai Sato, Fernando Aranda, Sylvère Durand, Alexandre Boissonnas, Jitka Fucikova, Laura Senovilla, David Enot, Michal Hensler, Margerie Kremer, Gautier Stoll, Yang Hu, Chiara Massa, Silvia C. Formenti, Barbara Seliger, Olivier Elemento, Radek Spisek, Fabrice André, Laurence Zitvogel, Suzette Delaloge, Guido Kroemer, Lorenzo Galluzzi
Format:	Artigo
Sprog:	Inglês
Udgivet:	Nature Portfolio 2020-07-01
Serier:	Nature Communications
Online adgang:	https://doi.org/10.1038/s41467-020-17644-0
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!